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What is already known about the topic?
•• Community nurses have a central role in assessing dying patients’ needs for pain and symptom control and enabling their 
timely access to appropriate medications.
•• A key element of the strategic approach to improving end-of-life care in the United Kingdom has been the introduction of 
‘anticipatory prescribing’. This involves the writing of prescriptions, usually by GPs, in anticipation of them being needed by 
a named patient and the development of area wide systems to ensure that medications can be dispensed ‘out-of-hours’.
•• Nurses often have limited knowledge and experiences with the relevant medications, lack resources and encounter power 
differentials between themselves and medical practitioners.
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Abstract
Background: In the United Kingdom, an approach to improving end-of-life care has been the introduction of ‘just in case’ or 
‘anticipatory’ medications. Nurses are often responsible for deciding when to use anticipatory medications, but little is known about 
their experiences.
Aim: To examine nurses’ decisions, aims and concerns when using anticipatory medications.
Design: An ethnographic study in two UK regions, using observations and interviews with nurses working in community and nursing 
home teams (n = 8).
Findings: Observations (n = 83) and interviews (n = 61) with community nurses. Nurses identified four ‘conditions’ that needed to 
be established before they implemented anticipatory medications: (1) irreversibility; (2) inability to take oral medication; (3) where the 
patient was able, they should consent and (4) decision had to be independent of demands or requests from patient’s relatives. By using 
anticipation medications, nurses sought to enable patients to be ‘comfortable and settled’ by provision of gradual relief of symptoms 
at the lowest dose possible. They aimed to respond quickly to needs, seeking to avoid hospital admission or medical call-out, while 
adhering to local prescribing policies. Worries included distinguishing between pain and agitation, balancing risks of under- and over-
medication and the possibility of hastening death.
Conclusion: Nurses take a leading role in the administration of anticipatory medications. Nurses apply consideration and caution to 
the administration of anticipatory medications but some experience emotional burden. Education, training and experience played a 
role in the nurses’ confidence and should continue to be central to efforts to improving the quality of palliative care in the community 
and nursing homes.
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What this paper adds?
•• Once medications had been correctly prescribed and dispensed, nurses identified four conditions which they perceived 
needed to be met before they could administer anticipatory medications: (1) symptoms that were both irreversible and due 
to entry into the dying phase; (2) inability to take oral medication; (3) patient consent where possible and (4) decisions made 
independent of influence from a patient’s relatives.
•• A key driver perceived by nurses was avoidance of hospital admission or medical call-out.
•• Some nurses considered such decisions to be emotionally burdensome. This was a key theme among nurses with less expe-
rience, resulting in worries about distinguishing between pain and agitation and concerns about the possibility of hastening 
death.
Implications for practice, theory or policy
•• Nurses require education, training and support from the multidisciplinary team to reduce the risk of emotional burden 
when administering anticipatory medications.
•• Nurses in this study reported that establishing that a patient had entered the dying or ‘end-of-life’ phase was a necessary 
condition for their use of anticipatory medication. Whether a narrow or broader interpretation of the ‘end of life’ is 
employed in practice may restrict the use of anticipatory medications in groups of patients with uncertain prognoses, poten-
tially leaving some with their pain and symptoms under or untreated.
•• Nurses must be free to respond to individual patients’ needs when making decisions relating to the use of anticipatory 
medications, rather than feeling the need to take into consideration policy drivers aimed at reducing ‘out of hours’ calls or 
hospital admissions.
Introduction
Community nurses have a central role in assessing dying 
patients’ needs for pain and symptom control and enabling 
their timely access to appropriate medications.1,2 A synthe-
sis of the small body of international research3 suggests that 
nurses often face difficulties because of limited knowledge 
and experience with relevant medications, lack of resources, 
and differentials in professional power between themselves 
and medical practitioners. In the United Kingdom, there 
has been a widespread introduction of ‘anticipatory pre-
scribing’ especially in community-based palliative care. 
This involves general practitioners (GPs) writing prescrip-
tions in anticipation of them being needed by a certain 
patient and the development of systems to ensure that med-
ications can be dispensed ‘out-of-hours’. Anticipatory 
medications (AMs) give considerable responsibility to 
community nurses, who must make decisions about their 
administration,4 however there is little evidence about nurs-
ing practice in this area. This article reports data from an 
ethnographic study involving 61 nurses working in two 
regions of England in community-based care, including 
nursing homes, with a view to addressing this gap.
Background
In the United Kingdom, the trend towards ‘anticipatory 
prescribing’ (see Box 1) has been actively encouraged to 
try to minimise the risk of patients suffering uncontrolled 
symptoms and distress, a key reason why terminally ill 
patients are admitted to hospital in contradiction of most 
people’s preferences.8
Box 1. What is anticipatory prescribing?
•  Anticipatory prescribing in the community is designed to ‘ensure that there is a supply of drugs in the patient’s home, 
combined with the apparatus needed to administer them, with the intention that they are available to an attending clinician 
for use after an appropriate clinical assessment’. (p. 1)5
•  A standard anticipatory prescription would include medication to treat pain, anxiety, nausea and respiratory secretions. The 
specific drugs prescribed may vary according to local area.
•  The Palliative Care Formulary recommends that these medications be provided in ‘just in case boxes’ also containing syringes 
and needles, local prescribing algorithms, permissions for medication use and patient information.6
•  Anticipatory medications are normally administered as an ‘as required’ or PRN dose injected into the subcutaneous tissue, 
although a ‘just in case box’ may also include medication for rectal administration such as diazepam or lorazepam.6
•  Practice guidance proposes that if a patient then requires regular doses, it is more effective and less intrusive to administer 
medication slowly and continuously over a 24 h period via a syringe driver pump.7
•  In order to set up a syringe driver, a separate prescription is required.
•  Anticipatory medications may be kept in the home to be used ‘as required’ for breakthrough symptoms until the medication 
in the syringe driver can be assessed and the dose adjusted as necessary.
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A UK study of community health professionals involved 
in home-based palliative care identified anticipatory pre-
scribing to be a three-stage process: (1) prescription writ-
ing, (2) dispensing and (3) administration.9 In the third 
‘administration’ stage, a nurse will commonly be the 
attending clinician who is responsible for deciding whether 
or not to administer the medications prescribed. Little is 
known about how nurses perceive or manage these respon-
sibilities or what challenges they face.10,11
Existing research shows that nurses working in pallia-
tive and end-of-life care contexts including care homes 
often experience stress, sometimes reporting a lack of 
confidence in and knowledge about managing pain and 
controlling symptoms in spite of their significant respon-
sibilities in this area of patient care.1,12,13 In addition, 
nurses sometimes feel they have too much responsibility 
without the necessary professional status or power to exe-
cute this effectively.3 International community-based 
research shows that nurses sometimes perceive that GPs 
lack experience and expertise in care of the dying.14–16 
Research in care homes has shown a lack of collaboration 
and communication between care home staff and GPs 
about patient care,13,17 which impedes the quality of end-
of-life care.
Authors of many studies recognise the need for proac-
tive care planning at the end of life14,15,18 supporting the 
aims of anticipatory prescribing to respond to symptoms 
promptly and prevent hospital admissions that are unwanted 
by patients.16 However, until now, the evidence base has 
primarily been descriptive reports of localised pilots,20 
audits18–20 or guidance and feasibility of use studies.24,25
This study examined community and nursing home 
nurses’ decisions to administer medications prescribed and 
dispensed in anticipation of anxiety, delirium and other 
difficult symptoms patients may experience at the end of 
life. In this article, we report the conditions that nurses 
identified were necessary before they used AMs, their 
aims in using these and what concerns they expressed 
about this area of practice.
Methods
Study design
The larger study from which this article is drawn comprised 
an ethnography of community nursing practice in two areas 
of England and a survey of community nurses in the same 
localities. In this article, we report findings from the ethnog-
raphy. Ethnography demands that the researcher becomes 
involved in the daily activities of the particular group under 
study (in this case, community nurses). The researcher then 
records, according to specified research objectives, aspects 
of the group’s work and experiences in a detailed way, 
before making analytical interpretations that allow consid-
eration of the broader implications.26
Setting
The study took place in two regions in England. The first, 
Lancaster and South Cumbria, covered a large semi-rural 
area serving a largely dispersed population. The second, the 
Midlands, was a socio-demographically varied area with a 
dense and varied population in urban districts, as well as a 
more dispersed population in rural areas. In each of the two 
geographic areas, two community nursing teams, involving 
district nurses and specialist palliative care nurses, and two 
care homes for older people registered to provide nursing 
care (i.e. nursing homes) were invited to take part using a 
convenience sampling approach. We employed a recruit-
ment approach used successfully in a previous study of 
end-of-life care in care homes,17 namely, working with key 
local end-of-life care stakeholders to publicise the study, 
identify potentially participating sites and then invite par-
ticipation via the team leader or care home senior nurse.
Participants
Study participants included registered nurses providing 
end-of-life care in each of the study sites, GPs responsible 
for anticipatory prescribing and community pharmacists 
responsible for dispensing. At the majority of sites, we 
continued to recruit study participants until data saturation 
for each site was achieved. At one nursing home site, this 
was not possible within the time constraints of the study. 
This article reports the findings from interviews and obser-
vations with nurses.
Data collection
Data collection took place between December 2011 and 
May 2012 and was conducted by two researchers (E.W. 
and H.M.).
Observations
Approximately 4 weeks was spent with each nursing team 
and in each nursing home to observe incidences of when 
prescriptions were written in advance of symptoms, as 
well as how, when and in what circumstances the pre-
scriptions were activated (for example, see Box 2). Each 
staff member gave written consent at the start of their 
involvement in the study, and verbal consent was gained 
from those in the field of observation at any particular 
time. Patients and their family carers were provided with 
information about the study and asked to verbally consent 
to or ‘opt out’ of aspects of their care being included in the 
observations. A record of this decision was placed in the 
patient’s notes. These observations allowed the study 
team to understand how the process of prescribing and 
using AMs unfolded in situ. The resultant data provided 
important contextual information for the subsequent 
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qualitative interviews, helped to guide the interview pro-
cess and enabled data triangulation.
Interviews
Nurses were invited to take part in interviews both to com-
plement the observational data and to gain their perceptions 
of the practical, organisational, ethical and communication 
issues they experienced. The aim was to recruit, at each 
site, up to 15 participants for interview from a range of pro-
fessionals, with particular focus on nurses. At each site, this 
was achieved, apart from one nursing home where AMs 
were not used during the study period. We chose to include 
specialist palliative care nurses in the study, as well as non-
specialist community and nursing home nurses since we 
were aware that specialist palliative care nurses often took 
the lead in supporting community and nursing home nurses, 
as well as GPs, in the use of AMs. Sampling was dependent 
upon who was involved in writing, dispensing and using 
AMs at the study sites. We used a flexible interview sched-
ule, adapted on the basis of the observations and informed 
by a literature review. Box 3 shows the aide-memoire 
employed. Interviews took place at the participant’s place 
of work and lasted between 10 min and 2 h. In addition to 
single interviews, six small group interviews were held: 
four with two nurses, one with three nurses and one with 
six nurses. Two interviews were conducted over the tele-
phone with nurses working out-of-hours for the conveni-
ence of the participants. Of the 61 nurses interviewed, 5 
were interviewed twice as directed by observations.
Box 2. Examples of observations.
Shadowing nursing staff involved in prescription decisions by attending
 • Home visits;
 • Meetings relating to prescribing;
 • Drug rounds;
 • Discussions between staff about patient care, including communication with family carers.
No intimate nursing care was observed.
Box 3. Overview of interview aide-memoire.
• Just to get started, can you tell me a bit about your role and your work with the community/nursing home team?
    What does your work involve on a daily basis?
    How long have you work in this field?
    How long have you worked with this team?
•  As you know, in this project we are interested in anticipatory prescribing for patients receiving end-of-life care. When you 
think of this issue, what comes to mind for you?
• Can you tell me about your role in (making, dispensing or using) anticipatory prescriptions?
• Do you feel you have enough knowledge of anticipatory prescribing?
• I would like you to try to recall a patient with whom you were involved who needed anticipatory prescriptions
    Can you tell me how you worked with other professionals involved in that person’s care?
    Were there any other non-professionals involved?
    Did you face any difficulties or challenges in the care of this patient? (and follow up more generally)
    What worked well?
    Is there anything that you would have liked to see done differently? (and follow up more generally)
•  Thinking more generally, and from your experience, how does medication management affect the quality of end-of-life care 
that patients receive? (follow up on any issues about place of care)
• Are there any things that you thought we would talk about that we have not covered?
Data recording and analysis
Hand written field notes were used to record observations. 
Field notes were typed up and anonymised. Interviews 
were digitally recorded and transcribed verbatim. A pre-
liminary coding framework was developed through dis-
cussion at project meetings and on the basis of a preliminary 
literature review.3 This was adapted as data collection pro-
ceeded. Each data source was coded by E.W. and J.S. sepa-
rately. Codes were then compared and discussed in order 
to group into themes and then further distilled into catego-
ries. The validity of the categories was checked with clini-
cal project advisors and an expert stakeholder group.
Findings
Across the eight study sites, 83 episodes of observation 
were conducted and interviews undertaken with 61 nurs-
ing participants (see Table 1). Table 2 provides a break-
down of the nurse participants by their professional role. 
Wilson et al. 5
In this study, Specialist Palliative Care Nurses were 
defined as nurses who had received additional training in 
palliative care (see Box 4).
Three overarching themes emerged from the data: (1) 
conditions that must be met before nurses would adminis-
ter AMs; (2) what nurses aimed to achieve by using the 
medication; and (3) nurses’ concerns about use. These 
themes and sub-themes are summarised in Table 3.
Necessary conditions identified by nurses in 
order to administer AM
Nurses identified four conditions, all of which needed to 
be met before they felt able to administer the medication: 
symptoms that were both irreversible and due to entry into 
the dying phase; inability to take oral medication; patient 
consent where possible and decisions made independent of 
influence from a patient’s relatives. These are discussed in 
turn below.
First, nurses described how they needed to be satisfied 
that the patient had irreversible symptoms due to the dying 
phase:
97 year old woman, lives with daughter … had a call from 
daughter to say patient had fallen out of bed and taken to 
A&E. Patient returned home. Request from daughter for 
[community nurses] to visit to give her mother something for 
pain. Nurse R visited but asked for a GP review of pain 
medication because she did not feel it was appropriate to use 
one of the [anticipatory] drugs in these circumstances – it was 
not why they had been prescribed and was not an end of life 
care need. (Observation field notes of community nurse team, 
1 March 2012)
Second, given that AMs were usually injectable drugs 
for subcutaneous use, nurses reported that they needed to 
be satisfied that the patient was unable to take oral medica-
tion. Third, nurses needed to be sure, where patients were 
alert and competent, that they consented to being given the 
medication. In the extract from observational field notes 
below, the patient’s wife had asked the nurse to go to see 
her husband as he had been struggling to take his oral med-
ication and appeared uncomfortable. When the nurse 
arrived, she assessed the patient and identified that he was 
in pain, with increasing anxiety. The nurse contacted a col-
league for assistance and together they reassessed the 
patient. They determined that he would benefit from the 
use of the AMs he had in place and then sought his consent 
to administer these to him:
Nurse B says ‘We have something that can make you less 
anxious, we can give you a little dose of something for the pain 
and something to help you settle’. [Patient] says ‘Whatever 
Table 1. Breakdown of data collection from nurses per site.
Site Interviews Observations
The Midlands 38 42
  •• •Community nursing 
teams × 2
23 14
 •• Care home teams × 2 15 28
Lancaster and Cumbria 23 41
  •• •Community nursing 
teams × 2
19 29
  •• Care home teams × 2  4 12
Total 61 83
Table 2. Number of interviews with nurses by professional 
group.
Professions Interviews conducted
Nursing home nurses 16
District/community nurses 27
Specialist palliative care nurses 18
Total 61
Box 4. Types of community nurse in the United Kingdom.
Community nurses – for the purposes of this article, this includes those qualified as district nurses.
Nursing home nurses – qualified nurses working in care home environments registered to provide nursing care.
Specialist palliative care nurses – those working at a Band 6 or 7* level with additional training in palliative care. These may include
  Clinical Nurse Specialists – these nurses provide advice and support to patients and families as well as having expertise in the 
management of symptoms. They may be assigned to work in patients’ homes or directly with care homes.
  Macmillan Nurses – some specialist palliative care nurses are badged under the brand of ‘Macmillan Cancer Support’, 
a national cancer charity. These nurses focus on providing advice for the management of complex symptoms and/or 
psychological distress.
  Advanced Nurse Practitioners – those participating in this study were based with general practitioner (GP) practices and had 
advanced training and prescribing skills. Their focus is on identifying indicators of comorbidities by undertaking basic medical 
tasks. They often liaise with care homes to try to manage patients’ symptoms proactively.
*In the United Kingdom, qualified nurses start at Band 5 and go up to Band 8. Nurses at Band 6 have advanced training, skills and experience; 
those at Band 7 have managerial roles in addition. For further information, see http://www.nhscareers.nhs.uk/explore-by-career/nursing/pay-for-
nurses/
For information about advanced nurse practitioners, see http://www.rcn.org.uk/__data/assets/pdf_file/0003/146478/003207.pdf
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you think is best’ Nurse B says ‘No it is only if you want it’. 
[Patient] says ‘If I am comfortable in the bed then I am ok’. … 
Nurse B explains (to the researcher) that Nurse D has assessed 
him and identified [additional] pain and agitation; they have 
now reassessed him together and get his consent to give him 
morphine and midazolam. (Observation field notes of a home 
visit with community nurses, 10 May 2012)
The extract above also illustrates the fourth condition that 
any decision taken by nurses to administer medications 
had to be independent of an instruction or request from the 
patient’s relatives. Nurses acknowledged that although 
relatives often provided the majority of personal care to 
patients and had considerable insight into their needs, they 
took great care not to be ‘unduly’ swayed by relatives’ 
judgements or requests:
I’ll say to the family do you mind just going in the other room 
so I can assess Mr so and so, because they greet you at the 
door say he’s in pain, he’s in pain and it’s very easy to have 
that autosuggestion and [then] you’re rushing and give them a 
big injection of diamorphine when actually he just needs a pee 
or something … [so] go and spend some time with the patient 
first and find out what’s going on, rather than just rushing and 
give an injection because the family are demanding on it, 
because I mean it is big pressure really and you’ve got to be 
confident enough to do that. (Specialist palliative care nurse, 
23 February 2012)
Nurses reported that what enabled them to establish 
whether these four conditions were in place was reflection 
on their prior experience and training, as well as knowl-
edge or familiarity with the particular patient and knowl-
edge of the patient’s condition.
Nurses’ aims in using AMs
The predominant aim expressed by nurses when using 
AMs was to ‘comfort’ and ‘settle’ dying patients:
It just settled her well … she’d been quite agitated, [her son] 
had gone out because he got upset, and then we gave her the 
injection and when he came back in she was just sleeping 
really peacefully. (Nursing home nurse, 1 February 2012)
… I just want them to be comfortable … because if they’re 
getting to that stage where they’re dying, it’s all about 
comfort, that’s what we’re trying to be there for. (Community 
nurse, 13 March 2012)
Another key aim was to enable management of symp-
toms in the patient’s home or care home to prevent patients’ 
transfer to hospital. In addition, nurses felt that AMs meant 
they often were able to avoid calling ‘out-of-hours’ doctors 
whom they perceived were highly likely to admit patients 
to hospital:
[for example] today, we’ve been able to, instead of having to 
phone someone, we’ve got medication here, we can use what 
we’ve got, … before having to call out a doctor to say this is 
happening or, God forbid, having to send someone in to 
hospital who is end of life … and I mean that is one of our 
fears, sending someone in [to hospital] who doesn’t [want to 
go]. There’s nothing they can do in hospital that we can’t do, 
and then having them pass away on a trolley in a busy A&E 
department … that’s not the type of environment the families 
want. (Nursing home nurse, 9 December 2011)
A third aim described by nurses in the use of AMs was 
to start at the lowest prescribed dose and work within local 
and national guidance; this was described as doing it ‘by 
the book’. At some sites, drug doses were prescribed within 
a narrow range allowing nurses some discretion. All nurses 
reported they would always start with the lowest dose, but 
that a range allowed them to increase the dose if necessary 
without calling the GP. However, not all were comfortable 
with using a range, with some seeing this as a difficult addi-
tional responsibility. Nurses expressed particular caution 
with those patients considered to be ‘opiate naïve’ or frail:
Table 3. Summary of presented themes.
Theme Sub-theme
Necessary conditions identified by 
nurses in order to administer AMs
•• Irreversible symptoms due to the dying phase
•• Inability to take oral medication
•• Where possible gain the patients’ consent
••  Decisions are independent of demands or requests from relatives
Nurses’ aims in using AMs •• Comfort and settle
•• Prevent transfers to hospital and avoid medical call-out
•• Start at the lowest dose and work within guidelines
Nurses’ concerns when using AMs •• Using the most appropriate drug for the presenting symptom
•• Used at the most appropriate time
•• Under medicating
•• Over medicating
•• Hastening death
AM: anticipatory medications.
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Interviewer:  So your stance is to err on the side of 
caution?
Nurse:  Side of caution yeah, it’s not always the 
answer when somebody’s needing relief 
from something, but I do think people 
absorb obviously drugs at a different 
rate, and it’s no good bombarding 
them. It’s better to give a small dose 
and then go back a bit later and you 
can always give them another small 
dose and just see. (Community nurse, 
20 April 2012)
Observational data showed how time was spent check-
ing the prescriptions and preparing the necessary drugs. 
Nurses often worked in pairs to make additional checks 
and provide support during decision-making:
Nurse B and Nurse Y check the notes and look for the grey box 
under the bed … They agree to give 5 mg of Midazolam and 
10 mg of Morphine Sulphate. … Nurse B explains to the 
patient: ‘the reason we are talking to each other is that we have 
to check everything’. They check the dates on the vials, and 
write on the lilac form. … Both nurses sign the administration 
sheet. They both check the dosage in the syringe. … They 
check the dose again with each other and give the midazolam 
first … then the morphine. … Nurse B then checks the left 
over vials and puts them in the sharps bin. Nurse B checks he 
has enough [medication] for the weekend. (Observation field 
notes, visit to patient’s home, 10 May 2012)
Nurses’ concerns when using AMs
Administering the medication raised a number of concerns 
for nurses. First, they were keen to distinguish between 
pain and agitation so as to administer the most appropriate 
drug but sometimes found this difficult:
It is a bit of a grey area, and you just have to use your clinical 
judgement. It depends on how well you know the patient and 
how they’ve been before, because you might have seen them 
in lots of pain but now they’re trying to climb out of bed and 
don’t know what they’re doing, in which case you put that 
down to agitation as well. I think, anecdotally, I’ve got no 
proof of this, but I think people would normally start on 
morphine and then add something a bit more sedating 
afterwards, just to see if it’s just the pain … (Community 
nurse, 13 March 2012)
In addition, nurses were keen to ensure AMs were used 
at the most appropriate time. AMs were welcomed because 
they offered nurses the opportunity to provide timely relief 
to a dying patient. However, some nurses expressed con-
cerns about using the prescribed medications ‘too soon’, 
that is, prior to recognising the patient as entering the 
dying phase:
It is up to us to know when to administer them. …
Interviewer: is there a point when it is a difficult decision?
I do think sometimes, because you do just question is it the 
right time? You know, although you know they’re in pain, are 
they in pain because this is it? Or have they just got a pain? 
And I think you have to differentiate. I think from experience 
you do know when. (Nursing home nurse, 12 December 2011)
Third, nurses noted that on some occasions starting at 
the lowest dose meant that it could take time to manage the 
patient’s symptoms; community nurses in particular were 
concerned about leaving patients under medicated:
I do sometimes worry about decisions that I’ve made and run 
through over in my head after I’ve made the decisions, which 
I suppose is only natural really. … Really it is not giving 
something when I should have done and having somebody in 
pain or in distress and I could have done something about it. 
So it’s probably that I find more fearful if that’s the right word 
[than over medicating someone]. (Community nurse, 17 
February 2012)
Despite all participants stating that they would always 
start on the lowest prescribed dose of the medication, some 
raised a fourth area of concern about over medicating 
patients and this resulting in unwanted side effects:
We don’t want to give them stuff that’s going to knock them 
out, we want to give them stuff to control the symptoms, and 
there’s a fine line between the symptoms and completely 
sedating them. … And I know nurses worry about that, about 
giving that last injection and families accusing them. … 
because [the nurse] rang me and she said oh god he’s gone 
really sleepy, we’ve given him some Midazolam. And I was 
just trying to reassure her really because it was a small dose, 
he was obviously really angst and uptight, you don’t want to 
see anybody like that. You see the other thing was he could 
have been exhausted from being in that state, so it could have 
had nothing to do with the Midazolam, it might have just 
relaxed him and at the end of the day these are small doses … 
(Community nurse, 14 May 2012)
In some instances, nurses recalled and echoed relatives’ 
concerns that if patients were sedated they would be una-
ble to take oral hydration or nutrition, thus potentially has-
tening death. In addition, some expressed concerns about 
whether medication to control pain and symptoms has-
tened death. This worry was particularly associated with 
opioids and tended to be expressed by nurses who had less 
experience and training:
Diamorphine, because whenever they get it you think they’re 
not going to be here much longer now, now they’ve had that. 
So I think now I think I don’t want to give them too much 
because am I hastening things. It’s quite scary but you’re on 
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your own when you’re making those decisions. (Nursing 
home nurse, 12 December 2011)
Some nurses, with a variable range of experience, 
recognised the continued influence of the infamous 
Shipman case27 not only on their own perceptions of 
morphine but also on those of prescribing GPs, other 
nurses and the public:
Well part of confidence and experience as well and the ripples 
of Shipman go very, very deep. … some people are very 
anxious or do have anxieties about giving them to very poorly 
patients. (Specialist palliative care nurse, 10 May 2012)
Nurses reported that their emotional burden in this area 
of practice was likely to be diminished by experience of 
working autonomously and or higher levels of training. 
Where possible, nurses reported working in pairs or liais-
ing with a team to gain support from colleagues and talk 
through decisions. Nurses generally sought support from 
other nursing colleagues and rarely mentioned contacting 
GPs other than to inform them that medication had been 
given or to request further prescriptions. However, all 
were aware of sources of specialist palliative care support 
such as Macmillan nurses, the local hospice or a palliative 
care consultant, and they all reported that they would call 
for advice if needed. However, the pace of the working 
environment, especially for community nurses, meant that 
there was little time to reflect on decisions made ‘in the 
field’ and made at some speed. This added to the feeling of 
burden that some nurses expressed as the following obser-
vational notes captures:
Seemingly not a moment for reflection on the circumstances 
and events around dying patients, or as on my visit last week, 
when a patient had died. Maybe this happens in a different 
setting, but my general impression is that this is the pace of 
work for them all, all of the time – weekdays and weekends. 
Is this the pace at which nurses consider and make decisions 
about AM? (Observation field notes, visit to community 
nursing team, 6 December 2011)
Discussion
The study reported here sheds detailed light on community 
and nursing home nurses’ experiences and roles in the use 
of AMs prescribed to relieve symptoms and distress at the 
end of life. This study builds on the research by Faull et al.5 
who described anticipatory prescribing as a process from 
prescription writing, to dispensing and administration. We 
have highlighted the necessary conditions identified by 
nurses for them to administer AMs, what they sought to 
achieve by the use of the medication and the concerns and 
challenges they encountered.
Nurses identified four ‘conditions’ that needed to be 
established before they would administer AMs: symptoms 
needed to be irreversible and due to entry into the dying 
phase; the patient should be unable to take oral medication 
to relieve the symptoms; where able, patient consent 
should be sought; finally, the decisions to administer medi-
cations from an anticipatory prescription needed to be 
made independent of demands or request from patient’s 
relatives. By administering the AMs, nurses sought to ena-
ble patients to be ‘comfortable’ and ‘settled’ by provision 
of relief of symptoms. They aimed to respond quickly to 
needs, seeking to avoid hospital admission or medical call-
out. In addition, nurses endeavoured to adhere to local pre-
scribing policies and guidelines by starting at the lowest 
dose and supporting colleagues through the processes of 
‘double checking’. Concerns were raised about distin-
guishing between pain and agitation, balancing risks of 
under- and over-medication and the possibility of hasten-
ing death.
In general, nurses working in community teams and in 
nursing homes in both regions had similar views about the 
use of AMs. The key differences related to their levels of 
experience and the availability of peer support. Those 
working in patients’ own homes had the support of large 
community nursing teams and reported being able to work 
in pairs to support junior staff. For nurses working in nurs-
ing homes, high staff turnover28 and the presence of only 
one or two qualified nurses on each shift meant that they 
lacked support, as well as confidence and experience in 
using AMs. The specialist palliative care nurses in the 
study often acted in an advisory and supportive role for 
those community and nursing home nurses who needed to 
use AMs.
Nurses in this study relied on their clinical skills and 
knowledge of the patient to assess the need to use AMs.11 
Our findings echo those of Eisenhauer et al.10 in a study of 
nurses’ critical thinking in relation to drug administration 
in North American hospitals. These authors suggest that 
although administration of medication can appear to be a 
‘technical task’, it entails considerable complex decision-
making skills and needs to be underpinned by sound 
knowledge to prevent harm and achieve good outcomes 
for patients. The complexity of this multifaceted aspect of 
nursing is intensified when nurses are working autono-
mously and in relative isolation from medical support 
available in acute settings.
In accounts reported here, some nurses advocated the 
use of prescriptions that allowed drugs to be administered 
within a small range. Yet many did not want or feel it was 
appropriate for them to have decision-making responsibili-
ties about dose ranges. Some considered such decisions to 
be emotionally burdensome, especially those with less 
training and experience. A number of other UK studies 
have illustrated the emotional strain felt by district nurses 
providing palliative and end-of-life care. This burden can 
be heightened by communication issues, limited knowl-
edge, experience of some conditions, a lack of support and 
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time pressures.1,12,15,29–31 Nurses working in care homes 
can often face similar barriers to providing good quality 
end-of-life care.13,17,32 There is now increasing evidence 
that symptoms are often undertreated, especially in older 
patients and in those with conditions other than cancer.33 
The effects of the murders committed by Shipman con-
tinue to influence public and professional attitudes.15,34,35
In this study, experience of dealing with dying patients, 
as well as having a clear understanding of the medications 
and their side effects, was considered by participating 
nurses to increase their confidence in administering medi-
cations. This echoes McIlfatrick and Curran’s31 observa-
tions of district nurses’ educational needs relating to the 
management of pain and symptoms, disease progression 
and drug therapies. Those in this study who reported work-
ing autonomously, such as those attached to ‘out-of-hours’ 
nursing teams, perceived themselves to be more confident 
than those with less experience; the latter tended to be 
nurses working in nursing homes where the use of AMs 
was a more recent phenomena.
Once AMs had been prescribed and were in place, 
most nurses reported that they perceived little need to 
contact the GP before initiating their use. AMs were wel-
comed because they offered nurses the opportunity to 
provide timely relief to a dying patient without the need 
for GP call-out. Nurses with little experience and clinical 
support who were involved in the use of AMs, such as 
those in nursing homes, reported greater readiness to 
contact the GP or sought support from specialist pallia-
tive care nurses.
Implications for practice
Findings from this study point to four central recommen-
dations for practice.
Level of decision-making. Nurses applied consideration and 
caution to the assessment of patients and making decisions 
to administer AMs, with the expressed aim of relieving 
symptoms and distress. It is important that the responsibil-
ity of such decisions be recognised by those providing and 
dispensing prescriptions in order for nurses to feel sup-
ported in the decisions that they make.
Multidisciplinary team (MDT) support and communica-
tion. Throughout this study, nurses reported working in 
pairs or liaising with colleagues during the decision-mak-
ing and administration process. It was clear that the weight 
of the decision whether or not to give AM, and the subse-
quent complexities of making sure the administration of 
the drug was correct, resulted in emotional burden for 
some nurses. Education, training and experience played a 
role in the nurses’ confidence and therefore should con-
tinue to be central to the provision of quality palliative 
care. Clear access to, and good communication with, 
nursing colleagues/managers, GPs, disease-specific and 
specialist palliative care services should be encouraged 
in order to sustain multidisciplinary relationships and 
sources of advice and support.
Policy versus clinical assessment. Nurses respected the seri-
ous nature of using AMs and wanted to make sure that 
they not only did what was best for the patient but also 
complied with local guidance and national regula-
tions.24,6,7 Concerns were expressed by some nurses about 
the possible under medication of patients’ symptoms due 
to the limited doses of drugs being prescribed and adher-
ence to the recommendations to always start at the lowest 
dose. In addition, a policy emphasis on preventing medi-
cal call-out may also have contributed to nurses continu-
ing with inappropriate doses to control symptoms rather 
than contacting a doctor to increase the dose when the 
doses prescribed had not been effective. It is therefore 
essential that nurses are free to respond to the patients’ 
needs as they present rather than making decisions based 
on perceived policy drivers.
Examining the ‘end-of-life’ label. Nurses in this study cited 
establishing that a patient had entered the dying or ‘end-of-
life’ phase was a necessary condition for their use of AM. 
However, both nurses and other health professionals are 
challenged by prognostication, particularly for conditions 
with uncertain trajectories of decline such as heart failure, 
chronic obstructive pulmonary disease (COPD) or frailty. 
Nor is there consensus about what the ‘end-of-life’ phase 
means and whether or not it is narrowly confined to dying. 
Faull et al.36 define the ‘end of life’ as ‘a focus on the last 
6-12 months of life’ (p. 3). Whether a narrow or broader 
interpretation of the ‘end of life’ is employed in practice 
may restrict the use of AMs in groups of patients with 
uncertain prognoses, potentially leaving some with their 
pain and symptoms under or untreated.
Limitations
This article has presented findings from interviews and 
observations with nurses. We used a convenience sam-
pling approach, potentially limiting the generalisability of 
the findings. GPs and pharmacists were also included in 
the study, and both play a key role in anticipatory prescrib-
ing. These data are presented elsewhere. Patients and rela-
tives were not included in this study, so we cannot be sure 
how they felt their contributions were perceived when 
decisions were made to administer AMs or how they 
viewed nursing practice in this area. However, a strength 
of our approach was the provision of data on the views and 
opinions of nurses who used AMs, alongside complemen-
tary observational data on the processes of decision-mak-
ing and associated discussions that took place when the 
medications were administered.
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